Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Growth prediction model for abdominal aortic aneurysms.
Ristl R, Klopf J, Scheuba A, Wolf F, Funovics M, Gollackner B, Wanhainen A, Neumayer C, Posch M, Brostjan C, Eilenberg W. Ristl R, et al. Br J Surg. 2022 Feb 1;109(2):211-219. doi: 10.1093/bjs/znab407. Br J Surg. 2022. PMID: 34849588 Free PMC article.
Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Ristl R, Schoder M. Lammer J, et al. Among authors: ristl r. J Am Coll Cardiol. 2013 Oct 8;62(15):1320-7. doi: 10.1016/j.jacc.2013.05.079. Epub 2013 Jul 10. J Am Coll Cardiol. 2013. PMID: 23831445 Free article. Clinical Trial.
Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial.
Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Beschorner U, Ristl R, Schoder M. Lammer J, et al. Among authors: ristl r. Cardiovasc Intervent Radiol. 2015 Feb;38(1):25-32. doi: 10.1007/s00270-014-1024-9. Epub 2014 Dec 5. Cardiovasc Intervent Radiol. 2015. PMID: 25472936 Clinical Trial.
Erratum to: Sustained Benefit at 2 Years for Covered Stents Versus Bare-Metal Stents in Long SFA Lesions: The VIASTAR Trial.
Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Beschorner U, Ristl R, Schoder M. Lammer J, et al. Among authors: ristl r. Cardiovasc Intervent Radiol. 2015 Jun;38(3):779-80. doi: 10.1007/s00270-015-1070-y. Cardiovasc Intervent Radiol. 2015. PMID: 25776757 No abstract available.
Fallback tests for co-primary endpoints.
Ristl R, Frommlet F, Koch A, Posch M. Ristl R, et al. Stat Med. 2016 Jul 20;35(16):2669-86. doi: 10.1002/sim.6911. Epub 2016 Feb 25. Stat Med. 2016. PMID: 26919166 Free PMC article.
Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
Kinstner CM, Lammer J, Willfort-Ehringer A, Matzek W, Gschwandtner M, Javor D, Funovics M, Schoder M, Koppensteiner R, Loewe C, Ristl R, Wolf F. Kinstner CM, et al. Among authors: ristl r. JACC Cardiovasc Interv. 2016 Jul 11;9(13):1386-92. doi: 10.1016/j.jcin.2016.04.012. JACC Cardiovasc Interv. 2016. PMID: 27388828 Free article. Clinical Trial.
Statistical analysis of Goal Attainment Scaling endpoints in randomised trials.
Urach S, Gaasterland C, Posch M, Jilma B, Roes K, Rosenkranz G, Van der Lee JH, Ristl R. Urach S, et al. Among authors: ristl r. Stat Methods Med Res. 2019 Jun;28(6):1893-1910. doi: 10.1177/0962280218777896. Epub 2018 Jun 19. Stat Methods Med Res. 2019. PMID: 29921167 Free PMC article.
138 results